13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 80 holding rows worth $1,322,563,000.
- Accession
- 0001583977-22-000006
- Filer
- CIK 1583977
- Filed
- 2022-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 80 entries on the cover page, a total value of $1,322,563,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,322,563,000 with VALUE read as thousands by filing date, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TURNING PT THERAPEUTICS | 90041T108 | COM | 2,484,220 | $186,938,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 5,500,000 | $77,000,000 | thousands by filing date | |
| ERASCA INC COM | 29479A108 | Stock | 10,505,554 | $58,516,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 2,029,158 | $57,283,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 950,000 | $42,959,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,995,066 | $38,884,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 3,170,872 | $37,987,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 1,425,000 | $35,312,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 3,000,000 | $35,100,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 450,000 | $33,422,000 | thousands by filing date | call |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 6,065,001 | $30,886,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,850,000 | $30,646,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 2,012,115 | $29,236,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 2,993,717 | $28,949,000 | thousands by filing date | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 1,525,000 | $27,572,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,875,000 | $27,375,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,730,691 | $27,051,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 184,894 | $26,941,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 1,800,000 | $26,280,000 | thousands by filing date | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,145,953 | $25,326,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 3,172,204 | $21,856,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 267,500 | $21,336,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 4,507,843 | $20,421,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 300,000 | $20,139,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 322,240 | $18,261,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 125,000 | $15,814,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 400,000 | $15,716,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 275,000 | $15,697,000 | thousands by filing date | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 2,840,389 | $15,338,000 | thousands by filing date | |
| GREENLIGHT BIOSCIENCES HOLDING | 39536G105 | Common Stock | 6,960,540 | $15,234,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,087,807 | $14,370,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 2,927,273 | $14,256,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,469,179 | $13,340,000 | thousands by filing date | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 2,326,660 | $12,936,000 | thousands by filing date | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 2,286,181 | $12,368,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 868,550 | $11,951,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 475,000 | $11,694,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 1,547,181 | $10,985,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 700,710 | $10,707,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 877,500 | $10,153,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,200,000 | $9,924,000 | thousands by filing date | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 780,643 | $9,547,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 2,082,000 | $8,474,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 205,000 | $7,852,000 | thousands by filing date | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 2,273,221 | $7,024,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 750,000 | $6,765,000 | thousands by filing date | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 2,486,386 | $6,589,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 608,123 | $6,069,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 2,038,215 | $5,809,000 | thousands by filing date | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 712,079 | $5,761,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 200,000 | $5,392,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 743,988 | $5,320,000 | thousands by filing date | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 1,174,723 | $5,298,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 50,000 | $4,648,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 482,413 | $3,864,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 403,787 | $3,816,000 | thousands by filing date | |
| ICOSAVAX INC | 45114M109 | COM | 651,393 | $3,732,000 | thousands by filing date | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 1,305,095 | $3,184,000 | thousands by filing date | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 1,983,168 | $2,776,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 100,000 | $2,763,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 150,000 | $2,270,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 394,500 | $1,850,000 | thousands by filing date | |
| GALECTO INC | 36322Q107 | COM | 1,020,238 | $1,765,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 198,382 | $1,660,000 | thousands by filing date | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 668,854 | $1,592,000 | thousands by filing date | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 616,786 | $1,591,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,154,424 | $1,224,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 150,000 | $1,136,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 392,167 | $1,110,000 | thousands by filing date | |
| CHEMOMAB THERAPEUTICS LTD | 16385C104 | SPONSORED ADS | 288,168 | $1,066,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 540,600 | $1,033,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 50,000 | $1,015,000 | thousands by filing date | |
| RENOVACOR INC | 75989E106 | COM | 500,000 | $1,014,000 | thousands by filing date | |
| GELESIS HLDGS INC | 36850R204 | COM | 626,108 | $970,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 300,000 | $900,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 319,057 | $571,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 199,547 | $549,000 | thousands by filing date | |
| IMV INC | 44974L103 | COM | 234,374 | $155,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 256,649 | $150,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 103,980 | $100,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001583977-22-000006 | this filing | 2022-08-15 | acceptance time not in the bulk data set |